Hovid Berhad (HOVID)-Financial and Strategic SWOT Analysis Review

Hovid Berhad (HOVID)-Financial and Strategic SWOT Analysis Review


  • Products Id :- GDPH82185FSA
  • |
  • Pages: 36
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Hovid Berhad (HOVID)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description-A detailed description of the company's operations and business divisions.

Corporate strategy-Analyst's summarization of the company's business strategy.

SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Hovid Berhad (Hovid), formerly Ho Yan Hor, is a pharmaceutical company that manufactures and commercializes pharmaceutical and herbal products, and health supplements. The company's product portfolio consists of ethical drugs, pharmaceutical products, dietary supplements, tocotrienols, herbal tea and consumer products. Hovid also specializes in special drug delivery systems including modified release formulations and bio-availability enhanced formulations. The company offers consumer products including skin care, hair care and health beverages. The company also offers contract manufacturing services to third party companies. The company has operations in Asia, Africa, the Americas, Europe, and the Pacific Islands. Hovid is headquartered in Ipoh, Perak, Malaysia.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Section 1-About the Company 5

Hovid Berhad-Key Facts 5

Hovid Berhad-Key Employees 6

Hovid Berhad-Key Employee Biographies 7

Hovid Berhad-Key Operational Employees 8

Hovid Berhad-Major Products and Services 9

Hovid Berhad-History 10

Hovid Berhad-Company Statement 13

Hovid Berhad-Locations And Subsidiaries 16

Head Office 16

Other Locations & Subsidiaries 16

Joint Venture 16

Section 2-Company Analysis 17

Hovid Berhad-Business Description 17

Hovid Berhad-Corporate Strategy 18

Hovid Berhad-SWOT Analysis 19

SWOT Analysis-Overview 19

Hovid Berhad-Strengths 19

Hovid Berhad-Weaknesses 20

Hovid Berhad-Opportunities 21

Hovid Berhad-Threats 22

Hovid Berhad-Key Competitors 23

Section 3-Company Financial Ratios 24

Financial Ratios-Capital Market Ratios 24

Financial Ratios-Annual Ratios 25

Performance Chart 27

Financial Performance 27

Financial Ratios-Ratio Charts 28

Section 4-Company's Lifesciences Financial Deals and Alliances 29

Hovid Berhad, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 29

Hovid Berhad, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 30

Hovid Berhad, Recent Deals Summary 31

Section 5-Appendix 32

Methodology 32

Ratio Definitions 32

About GlobalData 36

Contact Us 36

Disclaimer 36

List of Figures

Hovid Berhad, Performance Chart (2012-2016) 27

Hovid Berhad, Ratio Charts 28

Hovid Berhad, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 29

Hovid Berhad, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 30

List of Tables

Hovid Berhad, Key Facts 5

Hovid Berhad, Key Employees 6

Hovid Berhad, Key Employee Biographies 7

Hovid Berhad, Key Operational Employees 8

Hovid Berhad, Major Products and Services 9

Hovid Berhad, History 10

Hovid Berhad, Subsidiaries 16

Hovid Berhad, Joint Venture 16

Hovid Berhad, Key Competitors 23

Hovid Berhad, Ratios based on current share price 24

Hovid Berhad, Annual Ratios 25

Hovid Berhad (Cont...1), Annual Ratios 26

Hovid Berhad, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 29

Hovid Berhad, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 30

Hovid Berhad, Recent Deals Summary 31

Currency Codes 32

Capital Market Ratios 32

Equity Ratios 33

Profitability Ratios 33

Cost Ratios 34

Liquidity Ratios 34

Leverage Ratios 34

Efficiency Ratios 35

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Y.S.P. Southeast Asia Holding Berhad, Pharmaniaga Berhad, Kotra Industries Berhad, Chemical Company of Malaysia Berhad, Apex Healthcare Berhad

Hovid Berhad, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

select a license

Single User License
USD 125 INR 8098
Site License
USD 250 INR 16195
Corporate User License
USD 375 INR 24293

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com